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ABSTRACT 
This work demonstrated leukocyte count and two-part 
leukocyte differential from the whole blood based on a 
portable microflow cytometer system.  Leukocytes are 
selectively stained with a fluorescent dye, Acridine Orange 
(AO).  The blood sample is then pumped through a 
disposable microfluidic device for fluorescence sensing.  
Under blue LED excitation (460nm), the green fluorescence 
from DNA and the red fluorescence from RNA are detected 
simultaneously with two photomultiplier tubes (PMT).  
Leukocytes are counted and differentiated into two parts, 
lymphocyte versus non-lymphocyte, based on their 
fluorescence signatures.  The results, including leukocyte 
absolute count and lymphocyte ratio, matched well with the 
commercial hemacytometer counts (maximal error 9.0%, 
correlation coefficient ~0.8).  We also tested the system for 
the first time under a zero-gravity (zero-G) environment 
that facilitated its application in space missions. 
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INTRODUCTION 
Leukocyte count with differential is one of the most 
common clinical tests performed nowadays.  It provides 
important diagnostic information for diseases such as 
viral/bacterial infections, inflammations, allergies and the 
leukemia [1].  Besides, once the therapy is started, the test 
helps to monitor patient’s response to various treatments 
and recovery from illness.  Leukocyte count also finds 
useful applications in the space mission.  For instance, the 
lymphocyte ratio among leukocytes serves as a 
biodosimetry indicator of astronaut’s exposure to space 
radiation. 
Currently the test is performed either manually on an 
optical microscope or on an automated hemacytometer. The 
manual count takes a trained physician to distinguish each 
cell by observation, and the result is not very accurate.  The 
automated count has been proven to be more accurate and 
time efficient.  However, the conventional automated 
hemacytometers are usually bulky and expensive.  A micro 
blood counter holds the promise of a point-of-care solution 
with less cost and smaller footprint. 
Particle sensing (beads, erythrocyte or cultured cell 
lines) have been demonstrated on microfluidic devices by 
detecting the electrical impedance [2], scattered light [3] 
and fluorescent emission [4].  Previously we presented a 
feasibility study of leukocyte count with fluorescent 
sensing on an optical bench configuration [5].  In this work, 
we demonstrated the leukocyte count and two-part 
differential (lymphocyte versus non-lymphocyte) from the 
whole blood based on an improved portable system.  We 
also validated the system under a zero-G environment for 
human space missions. 
 
DETECTION PRINCIPLE 
Acridine orange is a cell permeable dye which mainly 
stains the nucleic acid. We use AO to selectively stain 
leukocytes in the whole blood obtained with fingerprick or 
venipuncture [6].  The DNA in leukocytes stains green 
(emission peak wavelength 525nm) and the RNA stains red 
(emission peak wavelength 650nm).  Mature erythrocytes 
in human blood lack DNA and RNA. Therefore normal 
erythrocytes are not stained by AO and don’t interfere with 
stained leukocytes.  Leukocytes are then counted by 
detecting the green and red fluorescence signals from 
individual leukocyte in a microfluidic channel.  Leukocytes 
two part differential, i.e. lymphocyte vs. non-lymphocyte, is 
achieved based on their different fluorescence signatures 
[7].  The specific staining of leukocytes by AO eliminates 
the need of erythrocytes lysis. 
Conventional automated hemacytometers use 
hydrodynamic focusing with sheath flow to guide samples 
into a small region of the detection zone.  A large volume of 
buffer fluid is necessary even for a small volume of the 
testing sample.  In our device, the use of sheath flow is 
avoided by constraining cells within the physical dimension 
of the microfluidic channel.  Therefore the total fluid 
volume, which limits the on-chip integration of the whole 
system, is largely reduced comparing to commercial 
hemacytometers. 
 
DEVICE FABRICATION 
The device was fabricated with standard soft 
lithography [5].  Briefly, a silicon wafer mold was made 
with lithography and deep reactive ion etching (DRIE).  
Then the polydimethylsiloxane (PDMS) prepolymer was 
mixed and casted onto the mold.  After a brief baking, the 
PDMS sheet was peeled off and the channel pattern on the 
mold was transferred to the PDMS block.  The device was 
finished by bonding the PDMS block to a glass substrate. 
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Fig.1 shows the microfluidic channel on a fabricated 
device.  The channel depth is 16μm and the channel width 
of the detection zone is 28μm.  The thickness of the PDMS 
block is controlled to be less than 6mm in order to 
accommodate the working distance of the optical 
condensing lens.  PDMS and glass are chosen as the device 
material for the ease of fabrication and their excellent 
optical properties in the wavelength range of this study. 
 
 
 
 
Figure 1: Top view of the fabricated microfluidic device.  The 
channel depth was 16μm.  The width of the detection zone was 
28μm.  The thickness of the whole device is less than 6mm.  
 
PORTABLE SYSTEM CONFIGURATION 
A portable prototype was constructed with commercial 
off-shelf components.  As shown in Fig.2, the optical 
components were assembled inside a black housing to be 
shielded away from the environmental light.  The 
microfluidic chip was mounted into the cage and could be 
replaced easily.  The whole system, including all the 
electrical components and the data acquisition module, was 
enclosed within an aluminum case of 12” x 9” x 5” in 
volume.  It was powered by either the 110V AC or a 5V DC 
source, and the recorded data was read out by a laptop 
through a USB port.  
 
 
 
Figure 2: The portable microflow cytometer prototype for 
leukocyte count and differential.  The upper-left schematic 
showed the design of the optical housing.  The lower-right picture 
showed the whole system except the laptop for signal 
visualization and data storage.    
 
The optical configuration is illustrated in Fig.3.  A blue 
LED with 460nm center wavelength is utilized as the 
excitation source.  The emitting light is collected with a 
narrow slit, purified by an excitation filter and condensed to 
the detection zone.  With a uniform illumination on the 
microfluidic channel, the hydrodynamic focusing with 
sheath flow is not required.  Fluorescent emission from the 
detection zone is collected and split into a green 
(510nm-560nm) channel and a red (>590nm) channel by 
one dichroic mirror and two emission filters inside the 
optical block.  Two PMTs are adopted to measure the 
intensity of the fluorescent emission, which is converted 
into digital signals by the data acquisition module.  The 
stained sample is loaded conveniently either by leaving a 
sample-loaded pipette tip connected to the inlet port or by 
inserting the inlet-tubing directly into a vertical sample vial.  
A mini peristaltic pump is used to draw the sample through 
the microflow cytometer. 
 
 
 
Figure 3: Schematic view of the optical configuration. 
 
RESULT AND DISCUSSION 
Fresh human whole blood with EDTA anticoagulant 
was purchased from HemaCare Corporation, CA, and 
tested on the microflow cytometer prototype.  A known 
volume of blood, e.g. 5μL, was drawn with a volumetric 
micropipette.  The blood sample was stained with 100μg/ml 
AO for 2minute at room temperature, and then diluted ten 
times with an aqueous solvent Ficoll-Paque before loading.  
Ficoll-Paque slows down the blood cell sedimentation 
process, thus can extend testing time.  The total sample 
volume was 50μL or less.  The pump rate could be adjusted 
from 1.0μL/min to 6.0μL/min.  A sampling rate of 50kHz 
was used for data acquisition. 
Detected fluorescence signals were stored and 
visualized on a laptop.  Fig.4 shows the typical time traces 
of the detected signals.  Each peak represents a stained 
leukocyte flowing through the detection channel.  
Leukocytes are detected for their green fluorescence from 
DNA and red fluorescence from RNA simultaneously.  The 
signal-to-noise-ratio (SNR) is 12 for the green peaks and 18 
for the red peaks on average.  The red signal has a higher 
SNR because the emission peak wavelength of AO shifts 
from 520nm (Green) to 650nm (Red) when binding to RNA, 
which helps to distinguish the stained leukocytes from the 
green background.   
Inlet Focusing Chamber Detection Zone Outlet 
1mm 
617
  
 
Figure 4: Time traces of measured signals from both the green 
channel and the red channel simultaneously. The blood sample 
was stained with 100μg/ml AO. 
 
Fig.5 is the scatter plot with the green fluorescence 
intensity versus the red fluorescence intensity detected from 
leukocytes.  The plot shows two clusters clearly separated.  
The upper-left cluster is generated by lymphocytes, 
whereas the lower-right cluster is contributed by 
granulocytes and monocytes.  Three-cluster differentiation 
is possible by AO staining with a low staining temperature 
and short testing time [7].  In our previous report, leukocyte 
was differentiated with only the red fluorescence signal, as 
shown in the inset of Fig.5.  The two-parameter signature 
from the current system shows better discrimination of 
lymphocytes against non-lymphocytes, thus improves the 
accuracy of the differential. 
 
 
 
Figure 5: Scatter plot of green fluorescence intensity vs. red 
fluorescence intensity detected from leukocytes.  The inset plot 
shows leukocyte differentiation by only red fluorescence in our 
previous report. 
Fig.6 compares the results of leukocyte absolute count 
and lymphocyte ratio between our microflow cytometer and 
a commercial hemacytometer.  The absolute count was 
calculated as dividing the detected leukocyte events by the 
volume of blood known from sample preparation.  The 
lymphocyte ratio was calculated as the percentage of the 
counted lymphocyte events within the total leukocyte 
events.  For five trials with different blood samples, the 
results match those from commercial hemacytometer 
counts by a maximal error 9.0% and a correlation 
coefficient ~0.8, which is within the error range of the 
commercial hemacytometer and the error range for clinical 
significance. 
 
 
(a) 
 
(b) 
 
Figure 6: Results of (a) leukocyte absolute count, and (b) 
lymphocyte ratio, compared with counts from a commercial 
hemacytometer. Error bar shows the standard deviation of 3 runs 
in each trial. 
 
Recently, we tested the prototype system on a zero-G 
flight at NASA Johnson Space Center.  The system 
underwent a transition between zero-G and two-G 
periodically during the test as the airplane repeated a 
parabolic trajectory.  The testing blood sample was 
prepared by the same staining recipe as the on ground test 
and loaded on the prototype system before takeoff.  The 
system was initiated to run the sample and to record signals 
before the airplane started the parabolic trajectory.  The 
acceleration data in terms of G-force was recorded by a 
separate accelerometer on the airplane.   
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Figure 6: Part of the fluorescent signals detected during the 
zero-G flight test. The inset shows the obtained scatter plot of the 
total data for two-part differential. The bottom curve shows the 
measured real-time G force during the test. 
 
As shown in Fig.7, the detected fluorescent signals 
from leukocytes shows no observable difference from those 
of the ground tests, and the similar two-cluster pattern is 
obtained in the scatter plot.  This result is reasonable as the 
gravity has no direct impact on the optical fluorescence and 
has only negligible influence on the cells’ position inside 
the microfluidic channel, which is dominated by the flow 
dynamics.  The zero-G and two-G cycles can be visualized 
due to the baseline shift of the signal.  We believe this is 
caused by the slight displacement of the microfluidic device 
and can be avoided by fastening the device more tightly in 
the future.  
 
CONCLUSION 
We fabricated a microfluidic device and constructed a 
portable system to demonstrate leukocyte count and 
two-part differential from human whole blood.  Leukocytes 
were selectively stained by 100μg/ml AO and diluted ten 
times with Ficoll-Paque.  Leukocyte was counted and 
differentiated into two parts, lymphocyte versus 
non-lymphocyte, by the green (510nm-560nm) and red 
(>590nm) fluorescence signature.  Results of leukocyte 
absolute count and lymphocyte ratio matched the 
commercial hemacytometer counts with a maximal error 
9.0% and a correlation coefficient ~0.8.  The prototype was 
also validated on a zero-G flight test. 
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